Meier–Gorlin syndrome and Wolf–Hirschhorn syndrome: two developmental disorders highlighting the importance of efficient DNA replication for normal development and neurogenesis by Kerzendorfer, Claudia et al.
GD
M
d
r
C
H
A
A
K
M
O
D
D
N
1
c
t
c
o
t
s
f
c
m
t
r
s
a
n
b
o
b
d
r
(
1
hARTICLE IN PRESS ModelNAREP-1785; No. of Pages 8
DNA Repair xxx (2013) xxx– xxx
Contents lists available at SciVerse ScienceDirect
DNA  Repair
jo ur nal home p age: www.elsev ier .com/ locate /dnarepai r
eier–Gorlin  syndrome  and  Wolf–Hirschhorn  syndrome:  Two
evelopmental  disorders  highlighting  the  importance  of  efﬁcient  DNA
eplication  for  normal  development  and  neurogenesis
laudia  Kerzendorfer,  Rita  Colnaghi,  Iga  Abramowicz,  Gillian  Carpenter,  Mark  O’Driscoll ∗
uman DNA Damage Response Disorders Group, Genome Damage & Stability Centre, University of Sussex, Brighton, East Sussex BN1 9RQ, United Kingdom
a  r  t  i  c  l e  i  n  f  o
rticle history:
vailable online xxx
eywords:
icrocephaly
a  b  s  t  r  a  c  t
Microcephaly  represents  one  of the  most  obvious  clinical  manifestations  of  impaired  neurogenesis.
Defects  in  the DNA  damage  response,  in  DNA  repair,  and  structural  abnormalities  in  centrosomes,  centri-
oles  and  the  spindle  microtubule  network  have  all  been  demonstrated  to  cause  microcephaly  in humans.
Work  describing  novel  functional  defects  in  cell  lines  from  individuals  with  either  Meier–Gorlin  syn-rigin licensing
NA replication
ormant origins
ucleosome assembly
drome  or Wolf–Hirschhorn  syndrome  highlight  the  signiﬁcance  of  optimal  DNA replication  and  S phase
progression  for  normal  human  development,  including  neurogenesis.  These  ﬁndings  illustrate  how  differ-
ent primary  defects  in  processes  impacting  upon  DNA  replication  potentially  inﬂuence  similar  phenotypic
outcomes,  including  growth  retardation  and microcephaly.  Herein,  we will  describe  the  nature  of the S
phase defects  uncovered  for each  of  these  conditions  and  highlight  some  of the  overlapping  cellular
features.
. Introduction
Neurogenesis is particularly sensitive to perturbations in cell
ycle dynamics. Two inter-related aspects of neurogenesis illus-
rate this; ﬁrstly, the requirement for an extremely rapid cell
ycle during embryogenesis to facilitate proliferative expansion
f the neuroepithelial stem cell layer [1]. Secondly, the need to
ightly control spindle pole orientation during the transition from
ymmetric to asymmetric cell division to enable neuronal dif-
erentiation and migration [2]. One of the most overt clinical
onsequences of impaired neurogenesis is microcephaly; a com-
on feature of many developmental disorders. Microcephaly is
he age-related reduction in occipital frontal circumference as a
esult of premature fusion of the cranial sutures due to an under-
ized brain. Microcephaly can have an environmental or genetic
etiology. Primary Microcephaly denotes a genetically heteroge-
eous group of conditions where severe microcephaly appears to
e the predominant/sole physical feature [3]. Over the past decade
r so, great advances have been made in uncovering the genetic
asis of Primary Microcephaly. Interestingly, all of the genetic
efects identiﬁed to-date involve proteins with known/presumedPlease cite this article in press as: C. Kerzendorfer, et al., Meier–Gorl
tal  disorders highlighting the importance of efﬁcient DNA replication
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oles in centrosome and/or spindle formation and maintenance
Table 1: MCPH1-8). Cells from these individuals invariably exhibit
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consequent defects in centrosome stability, spindle pole organisa-
tion and chromosome segregation (Table 1).
Microcephalic Primordial Dwarﬁsms represent an additional
group of conditions wherein pronounced growth retardation
is associated with severe microcephaly. Speciﬁc examples
include Microcephalic Osteodysplastic Primordial Dwarﬁsm Type-
II (MOPD-II), Seckel syndrome and Meier–Gorlin syndrome.
Mutations in PCNT (pericentrin), which encodes an important struc-
tural pericentriolar protein, cause MOPD-II, and similar to Primary
Microcephaly, spindle abnormalities have been documented in
PCNT-mutated MOPD-II cell lines [4,5]. The ﬁrst genetic defect iden-
tiﬁed in Seckel syndrome was  in ATR (Ataxia Telangiectasia and
Rad3-related), the gene encoding the apical protein kinase (ATR)
of the DNA damage response (DDR) [6]. Recently, new ATR muta-
tions have been described in Seckel syndrome individuals, along
with novel defects in ATRIP: the obligate co-stabilising partner
of ATR [7,8]. Cells from these patients exhibit DNA replication
abnormalities, cell cycle checkpoint defects as well as centrosome
abnormalities [9]. In fact, cell lines from MCPH1-mutated Primary
Microcephaly and PCNT-mutated MOPD-II have been shown to
exhibit defects in the ATR-dependent DDR, highlighting overlap-
ping functional deﬁciencies of these different proteins [4,10].
ATR is essential for mammalian embryonic and indeed somatic
cell viability [11–13]. Distinct transgenic mouse models of hypo-in syndrome and Wolf–Hirschhorn syndrome: Two developmen-
 for normal development and neurogenesis, DNA Repair (2013),
morphic ATR-deﬁciency have shown that ATR is essential for
development and for tissue homeostasis [14,15]. It has been pos-
tulated that impaired ATR function results in elevated embryonic
replicative stress-induced genomic instability, with consequent
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Table  1
Defects in genes that encode proteins with centrosomal and/or spindle localisations and/or functions are associated with severe microcephaly in humans. The reader is
referred  to several comprehensive recent reviews concerning the underlying aetiology of microcephaly. These reviews also overview various cell and animal models for
many  of the defects listed here [3,74,75].
Gene Disorder Protein location Functional comments
MCPH1 (Microcephalin) Primary Microcephaly:
MCPH1 locus.
Centrosome Patient cells exhibit supernumerary centrosomes, premature
chromatid condensation, delayed decondensation and defective
ATR-dependent G2-M checkpoint activation [10,76–79].
ASPM Primary Microcephaly:
MCPH5 locus.
Spindle pole Deﬁciency alters the cleavage furrow orientation in mitotic cells in the
neuroepithelium [2,80].
CDK5RAP2 (CEP215) Primary Microcephaly:
MCPH3 locus.
Centrosome Required for centrosome cohesion and microtubule nucleation of the
-tubulin ring complex. Interacts with PCNT [81–88].
CENPJ (CPAP) Primary Microcephaly:
MCPH6 locus and
Seckel syndrome.
Centrosome Functions in centriole duplication together with STIL. Loss of
expression leads to cell cycle arrest with multipolar spindles.
Mutations associated with Primary Microcephaly and Seckel syndrome
individuals [81,89–92].
STIL (SIL) Primary Microcephaly:
MCPH7 locus.
Spindle pole Functions in procentriole formation and centriole duplication and
interacts with CPAP (CENPJ) [91,92].
WDR62 Primary Microcephaly:
MCPH2 locus.
Spindle pole Defects associated with microcephaly and complex cortical
abnormalities in humans suggestive of neuronal migration defects
[93–95].
CEP152 Primary Microcephaly
MCPH4 locus and
Seckel syndrome.
Centrosome Required for the centrosomal loading of PLK4 and CPAP for effective
centriole duplication. Different mutations associated with Primary
Microcephaly or Seckel syndrome. CEP152-mutated Seckel syndrome
cells exhibit multiple mitotic abnormalities including multipolar
spindle and aneuploidy [90,96–100].
CEP63 Primary Microcephaly
with mild Seckel
syndrome
Centrosome Forms a ring-like structure at the centrosome with CEP152 and
controls centrosome number. CEP63 was  also identiﬁed as an ATR
substrate required for spindle checkpoint activation [100,101].
CEP135 Primary Microcephaly:
MCPH8 locus.
Centrosome Presumed role in centriole biogenesis. Co-localises with PCNT. Patient
cells exhibit supernumerary centrosome and multipolar spindles
[102–104].
PCNT  (Pericentrin) Microcephalic
Osteodysplatic
Primordial
Dwarﬁsm-Type II
(MOPDii).
Centrosome Interacts with PCM1 and g-tubulin to coordinate microtubule
nucleation. Defects cause MOPDii with impaired ATR-dependent DDR
and  G2-M checkpoint activation [4,5].
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ttrition, particularly during embryogenesis, of tissue systems with
 high replicative index such as the developing brain [14–17]. More-
ver, Mokrani-Benhelli et al. have demonstrated, using DNA ﬁbre
nalysis, reduced replication fork velocity, decreased inter-origin
istance and elevated fork stalling in cells from an ATR-mutated
ndividual [8]. Therefore, it seems logical that a primary defect in
he process of DNA replication itself could, if viable, potentially also
mpart a disproportionate adverse impact on neurogenesis.
. Meier–Gorlin syndrome and origin licensing
Meier–Gorlin syndrome, variously described as “ear, patella,
hort stature syndrome” and/or “microtia, absent patellae,
icrognathia syndrome”, is a rare autosomal recessive disorder
haracterised by growth retardation associated with microcephaly,
mall ears (microtia) and small/absent patellae (knee caps) [18–21].
n early 2011, complementary reports described genetic defects in
everal distinct components of the DNA replication origin licensing
achinery in Meier–Gorlin syndrome individuals and in patients
nitially clinically diagnosed as Seckel syndrome or non-speciﬁc
icrocephalic Primordial Dwarﬁsm [22–24]. Mutations were iden-
iﬁed in ORC1, ORC4 and ORC6 of the origin recognition complex
ORC), along with CDT1 and CDC6; key additional important reg-
lators of origin licensing. ORC2-5 constitutes the core ORC with
RC1 and ORC6 transiently associating with the complex. Binding
f ORC to chromatin demarks an origin of replication through thePlease cite this article in press as: C. Kerzendorfer, et al., Meier–Gorl
tal  disorders highlighting the importance of efﬁcient DNA replication
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ormation of the pre-replication complex (pre-RC) via its associ-
tion with additional factors including MCM  proteins, CDT1 and
DC6 (Fig. 1) [25]. MCM2-7 complexes are loaded onto DNA in
xcess of other DNA replication factors, including ORC, to allow aPlays a role in coordinating asymmetric cell division. Defects
associated with MPD  [105].
maximum degree of ﬂexibility in licensing replication initiation, for
example to enable dormant origin ﬁring under certain conditions
thereby ensuring genome stability (Fig. 1) [25–30].
In the various Meier–Gorlin syndrome cohorts identiﬁed as hav-
ing mutations in replication licensing components there appeared
to be a wide range of variability for most of the core clinical
features aside from the growth retardation which was marked
[22–24]. Microcephaly, in the context of severe growth retardation,
is relative, as head circumference is often in fact proportion-
ate to the reduced body size. A notable exception is ATR- and
ATRIP-mutated Seckel syndrome, where microcephaly appears
even more pronounced relative to the severe growth retarda-
tion [6,7,31]. Interestingly, some of the ORC1-mutated individuals
exhibited disproportionately reduced head circumference com-
pared to height in contrast to those with defects in ORC4, ORC6, CDT1
and CDC6 [22–24]. This may  reﬂect differing levels of hypomor-
phicity between different mutations, genetic background/ethnicity
of the individuals and/or differential impacts of defects in differ-
ent genes. Detailed anthropometric data on multiple Meier–Gorlin
syndrome individuals has recently been published [32].
2.1. DNA replication defects in ORC1-mutated Meier–Gorlin
syndrome
Together with the Jeggo group, we  performed detailed
functional characterisation of cell lines from two differentin syndrome and Wolf–Hirschhorn syndrome: Two developmen-
 for normal development and neurogenesis, DNA Repair (2013),
ORC1-mutated individuals, identifying several cellular phenotypes
consistent with an impaired coordination between origin licens-
ing, DNA replication and S phase progression [23]. We observed
reduced ORC1 and ORC2 chromatin enrichment in an exponentially
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Fig. 1. The impact of limiting origin licensing on DNA replication timing. Origins at genomic loci are ‘licensed’ by virtue of assembly of a pre-replicative complex composed
of  ORCs and the MCM2-7 helicase complex. These are ‘ﬁred’ thereby initiating DNA replication from these loci through the concerted action of various additional factors
liberating MCM  helicase activity. Once licensed origins are ﬁred, replication bubbles formed with newly synthesised DNA (grey) expand in a bi-directional fashion moving
towards each other before ﬁnally converging (WT; wild-type). If a limiting number of origins are licensed and ﬁred, perhaps as in the case of ORC1-mutated Meier–Gorlin
syndrome cells (ORC1), these replication bubbles have a greater distance to traverse/replicate before merging. Firing of dormant origins between these bubbles are thought
to  represent a means of ensuring effective replication and preserving genome stability. In the absence of efﬁcient dormant origin ﬁring between these disparately spaced
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aeplication bubbles, it would take longer to replicate this region, compared to WT.
oth  cellular phenotypes observed in ORC1-mutated patient LCLs.
rowing lymphoblastoid cell line (LCL) from an ORC1-mutated
atient. Consistent with reduced origin licensing capacity in this
ontext, we observed reduced licensing of an ectopically supplied
BV-oriP episome system and impaired re-replication following
ytokinesis inhibition in ORC1-patient LCLs compared to WT.  The
AH (bromo adjacent homology) domain of ORC1, a region known
o be important for ORC1 stability, has recently been shown to
peciﬁcally bind to histone H4-lysine-20-dimethylated (H4-K20-
e2) [33,34]. As H4-K20-me2 appears to be enriched for in at least
wo known human replication origins, it has been suggested that
his interaction is an important mechanism of bringing ORC to ori-
ins [33]. Interestingly, several ORC1 patient mutations map  to the
AH domain including a recurrent mutation (p.Arg105Gln) found
n several unrelated Meier–Gorlin syndrome cases [22–24].
Using distinct BrdU labelling strategies, we observed prolonged
1 and delayed S phase entry in the ORC1-patient cells [23]. These
henotypes could be reﬂective of a reduced capacity to attain
 minimum amount of pre-RC loaded origins to enable S phase
ntry; essentially prolonged engagement of the licencing check-
oint (Fig. 1). Interestingly, we also observed a modest although
oticeable delay in S phase progression in ORC1-mutated patientPlease cite this article in press as: C. Kerzendorfer, et al., Meier–Gorl
tal  disorders highlighting the importance of efﬁcient DNA replication
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ell lines compared to WT.  Therefore, the cell cycle perturbations
n this context were evident prior to S phase entry but also dur-
ng S phase progression. Further, using [3H]-thymidine labelling
nd sucrose gradient sedimentation we found evidence for shorterould result in smaller replication intermediates and delayed S phase progression;
newly replicated DNA molecules in ORC1-LCLs compared to WT
[23]. This latter cellular phenotype could be reﬂective of a combina-
tion of: (i) a reduced number of ﬁred origins, (ii) slower movement
of forks from ﬁred origins, (iii) reduced dormant origin ﬁring in the
ORC1-mutated LCLs (Fig. 1).
Interestingly, we did not observe elevated levels of genomic
instability in these patient-derived LCLs [23]. This is usually a
notable outcome when dormant origin ﬁring capacity is strongly
suppressed, for example, via reduction or mutation of MCM com-
plex components. Consistent with this, several mouse models with
hypomorphic alleles of MCM  components (Mcm2IRES−CreERT2 and
Mcm4Chaos3) are highly cancer prone [35,36]. An elevated cancer
incidence has not been described to date in Meier–Gorlin syn-
drome [37]. This may  be reﬂective of the hypomorphic nature of
ORC1 mutations in the patient LCLs and/or the differing roles of
the MCM2-7 complex and the ORC complex during origin licens-
ing and ﬁring, and consequently upon genome stability during DNA
replication. For example, we  have found that whilst DNA replica-
tion in ORC1-patient LCLs is hypersensitive to inhibition following
treatment with a low dose of HU relative to WT,  these cells can
apparently resume DNA replication efﬁciently within a short timein syndrome and Wolf–Hirschhorn syndrome: Two developmen-
 for normal development and neurogenesis, DNA Repair (2013),
(Fig. 2). As mentioned, MCM2-7 is loaded far in excess of other repli-
cation factors and plays a key role in determining the efﬁciency of
dormant origin ﬁring under conditions of replicative stress. Inter-
estingly, multiple congenital hypomorphic defects in MCM4 have
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Fig. 2. ORC1-mutated Meier–Gorlin syndrome patient LCLs are hypersensitive to replication arrest following treatment with a low dose of HU. LCLs from wild-type (WT) and
ORC1-mutated Meier–Gorlin syndrome (ORC1) were treated with 250 M HU and pulse labelled with BrdU 15 min prior to the end of each time point. Representative ﬂow
cytometry proﬁles are shown on the left hand side (BrdU labelled cells in green). The graph on the right hand side shows BrdU levels (mean ± sd from three independent
determinations). Under these conditions, treatment with HU results in a greater inhibition of DNA replication at 2 h in ORC1-mutated LCLs compared to WT.  But, this difference
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thought to underlie the seizures frequently seen in WHS  individuals
[53–55]. Genomic analysis of patients with differing sized overlap-s  negligible at 6 h post-treatment indicating the ability of the ORC1-mutated cells t
o  colour in this ﬁgure legend, the reader is referred to the web version of the articl
ecently been described in humans, associated with familial gluco-
orticoid deﬁciency secondary to adrenal insufﬁciency, selective
K (natural killer) cell deﬁciency and growth retardation. Fur-
hermore, cells from these individuals exhibit elevated levels of
enomic instability [38–40]. Therefore, whilst there is some clin-
cal overlap between the disorders associated with defects in the
RC complex and MCM  complex (e.g. growth retardation), there
lso appears to be some obvious distinctions. The basis of these
istinctions is not clear. Nevertheless, impaired Mcm2  expression
as been shown to inﬂuence cellularity and replicative capacity in
he subventricular zone in the brains of Mcm2IRES−CreERT2 mice, sug-
esting that pre-RC complex components other than those of the
RC are also required for normal neurogenesis [41].
.2. Non-canonical roles for ORC outside of origin licensing
Interestingly, ORC1, along with other ORC components, have
een implicated in several additional functions outside of origin
icensing. This may  be relevant when considering how genotype
ranslates into clinical phenotype for multigenic defects in ORC
omponents. For example, human ORC1 has been shown to actively
ocalise to centrosomes in a cyclin A dependent manner and
o be required for controlling centriole and centrosome number
ndependently of DNA replication [42]. This is particularly rele-
ant when considering the underlying genetic defects associated
ith severe microcephaly in humans (Table 1). Further roles for
uman ORC have been invoked in the maintenance of higher order
hromatin structure, speciﬁcally heterochromatin maintenance via
irect interactions of ORC1 and ORC3 with heterochromatin pro-
ein 1 (HP1)-;  and in several lower organisms for transcriptional
ene silencing, cytokinesis, sister chromatid cohesion and even for
ibosome biogenesis ([43,44] and references therein). It is possible
hat adverse impaction on any/all of these process could inﬂuence
ormal neurogenesis.
Interestingly, Orc2-5 and Orc6, in contrast to Orc1, were found
o be strongly expressed in mouse post-mitotic neurons potentiallyPlease cite this article in press as: C. Kerzendorfer, et al., Meier–Gorl
tal  disorders highlighting the importance of efﬁcient DNA replication
http://dx.doi.org/10.1016/j.dnarep.2013.04.016
uggesting functions outside of DNA replication [45]. Speciﬁcally,
hese ORCs were found to preferentially localise to non-nuclear
embrane compartments (microsome, synaptosome) of dendrites.
n fact, siRNA-mediated silencing of Orc3 and Orc5 in culturedver from these replication stalling conditions. (For interpretation of the references
mouse hippocampal pyramidal neurons suggested a role for these
ORC subunits in dendrite growth and arborisation/branching [45].
Dendrites are the major sites of information processing and storage
in the brain. Additionally, latheo (lat), the Drosophila orc3 homo-
logue, was originally identiﬁed using transponson-mutagenesis in a
behavioural screen for olfactory memory mutants, suggesting a role
here in neuronal plasticity [46]. Mutations in lat were also found to
impair Drosophila neuroblast proliferation with an associated site
speciﬁc structural brain abnormality (i.e. reduction in mushroom
body neupillar volume) [47].
Collectively, multiple roles for various ORC and MCM  complex
components have been invoked in different aspects of neurogen-
esis and neuronal function using cell and animal model systems.
The identiﬁcation of pathogenic mutations in origin licencing
components in Meier–Gorlin syndrome highlights for the ﬁrst
time the requirement for regulated origin licensing for normal
human development, but also highlights the association between
mutant ORC1-induced abnormalities in DNA replication/S phase
and microcephaly.
3. Wolf–Hirschhorn syndrome
Wolf–Hirschhorn syndrome (WHS) is a contiguous gene dele-
tion genomic disorder caused by hemizygous deletion of the
sub-telomeric region of chromosome 4 (human somatic autosome;
HSA 4p16.3) (Fig. 3A). WHS  is a multigenic, highly variable devel-
opmental disorder whereby the severity and clinical spectrum
depends on the size of the deletion. WHS  is associated with growth
retardation, microcephaly, developmental delay, seizures, car-
diac abnormalities and a characteristic facial appearance [48–52].
Speciﬁc genes within the deleted regions have been function-
ally implicated in this condition. For example, haploinsufﬁciency
of LETM1,  which encodes a mitochondrial Ca2+/H+ antiporter, isin syndrome and Wolf–Hirschhorn syndrome: Two developmen-
 for normal development and neurogenesis, DNA Repair (2013),
ping deletions has enabled the demarcation of a common smallest
region of overlap whose haploinsufﬁciency is thought to underlie
the core clinical features of this disorder: the Wolf–Hirschhorn
syndrome critical regions (WHSCR, WHSCR2) (Fig. 3A) [56,57].
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Fig. 3. Wolf–Hirschhorn syndrome cells exhibit DNA replication defects spontaneously and following DNA damage. (A) Schematic representation of the region on human
chromosome 4 that is hemizygously deleted in Wolf–Hirschhorn syndrome showing the relative locations of some of the key genes implicated in this disorder. The red
boxes  denote the critical regions; WHSCR and WHSCR2. WHSCR incorporates part of WHSC1 gene, also known as NSD2/MMSET, and the entire WHSC2/NELF-A gene. WHSCR2,
includes LETM1 and part of WHSC1//NSD2/MMSET but not WHSC2/NELF-A. The patient LCLs used here have overlapping deletions, indicated by the grey bars. (B) As the
replisome (blue) progresses, histones on the un-replicated template must be remodelled onto each of the newly synthesised strands. This segregation of parental histones
(grey)  between both newly synthesised DNA molecules ensures that faithful transmission of epigenetic markers from the parental chromatin onto the newly synthesised
chromatin. De novo assembly of newly synthesised histones (white) completes the nucleosome complement on these molecules. (C) DNA replication in Wolf–Hirschhorn
syndrome LCLs is sensitive to UV-induced DNA damage. The left hand panels show BrdU ﬂow cytometry proﬁles from wild-type (WT) and Wolf–Hirschhorn syndrome
LCLs  (patient line A(83)), either untreated (Unt) or 3 h post-irradiation with 10 J/m2 of ultraviolet (UV) light. Cells were pulse-labelled with BrdU for 15 min  just prior to
harvesting. The boxed area denotes cells in mid-S phase but with a low amount of incorporated BrdU (i.e. ongoing DNA synthesis). The right hand graph shows that following
UV  treatment, the Wolf–Hirschhorn syndrome LCLs have relatively more cells in this area compared to WT (mean ± sd of three experiments). (For interpretation of the
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NELF-A (Negative Elongation Factor-A), otherwise known as
HSC2 (Wolf–Hirschhorn Syndrome Critical gene 2), encodes a
omponent of the Negative Elongation Factor (NELF) complex [58].
his complex inhibits RNA polymerase II progression early during
ranscriptional elongation, inducing proximal promoter pausing,
hich can affect the expression of genes in both a negative and
ositive manner [59,60]. Telomeric to WHSC2, and invariably hap-
oinsufﬁcent in WHS, resides SLBP, a gene encoding Stem Loop
inding Protein (Fig. 3A). SLBP is essential for histone biogene-
is and the regulated degradation of histone mRNA species at the
nd of S phase [61]. Histone mRNA’s, whose synthesis is strictly
estricted to S phase, are the only mammalian mRNA’s lacking a
oly-A tail, instead possessing a conserved stem-loop structure to
hich SLBP binds [62–64]. Therefore, SLBP plays a crucial role in
egulating histone synthesis and availability during S phase [65,66].
egulated histone synthesis and deposition is essential to sustain
n-going DNA replication but also to facilitate chromatin forma-Please cite this article in press as: C. Kerzendorfer, et al., Meier–Gorl
tal  disorders highlighting the importance of efﬁcient DNA replication
http://dx.doi.org/10.1016/j.dnarep.2013.04.016
ion and to preserve epigenetic markers [67]. Indeed SLBP has
een shown to be required for S phase progression in human cells
68,69]. Interestingly, NELF-A/WHSC2 can also target SLBP to the
′-end of histone pre-mRNA’s, highlighting an important functionalarticle.)
connection between these two proteins, both of whom are under-
expressed in WHS  [58].
The signiﬁcance of these interactions with respect to efﬁcient
DNA replication and S phase progression in WHS-patient cells has
recently been described by Kerzendorfer et al. Using a unique
collection of WHS  patient-derived LCLs with differing deletions,
together with the Vermeesch group, we found a signiﬁcantly
reduced capability to synthesise DNA, associated with delayed S
phase transition, relative to wild-type (WT) LCLs [70]. The latter
phenotype in particular being reminiscent of the impaired S phase
progression documented in ORC1-mutated patient LCLs [23]. In the
context of WHS, these S phase defects could be attributed to hap-
loinsufﬁciency of SLBP and/or NELF-A/WHSC2 [70]. Interestingly,
reduced SLBP and/or NELF-A/WHSC2 expression did not result in a
concurrent reduction in overall histone levels, but rather was  asso-
ciated with impaired histone deposition and altered higher order
chromatin structure in WHS  LCLs. In fact, evidence for impaired
parental histone segregation (i.e. recycling of parental histone at the
replication fork to preserve epigenetic marks) was  suggested byin syndrome and Wolf–Hirschhorn syndrome: Two developmen-
 for normal development and neurogenesis, DNA Repair (2013),
the increased level of unbound histone H3-K9-me3 in WHS  LCLs
(Fig. 3B). H3-K9-me3 is not a marker of de novo histones, but a
feature of parental heterochromatin [67]. A reduced capacity to
faithfully maintain epigenetic memory could have a serious effect
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n tissue-speciﬁc developmental programmes. These data provide
ovel pathomechanistic insight into two genes frequently deleted
n WHS  and functionally implicates under-expression of SLBP, for
he ﬁrst time, in several novel WHS  cellular phenotypes [70].
Interestingly, haploinsufﬁciency of both SLBP and NELF-
/WHSC2 was also associated with sensitivity to DNA damage in S
hase [70]. WHS  patient-derived LCLs were found to be extremely
ensitive to replication arrest and killing by camptothecin (CPT), the
opoisomerase-I (Topo-I) inhibitor that induces DNA double strand
reak formation following collision of DNA replication and tran-
cription forks with CPT-stabilized Topo-I cleavable complexes on
NA. Furthermore, we found that DNA replication in WHS  patient-
erived LCLs was sensitive to other forms of DNA damage consistent
ith a stochastic problem during S phase in these cells. For exam-
le, following irradiation with UV, we observed a greater decrease
n BrdU incorporation in S phase cells from multiple WHS-patient
erived LCLs compared to WT  (Fig. 3C). These ﬁndings could also be
eﬂective of an impaired ability to dynamically modulate nucleo-
ome and/or higher chromatin structure at replication forks when
hey encounter damage in the template DNA [71–73].
. Conclusions
Cell division is fundamental for normal neurogenesis. Whilst
erturbation of centrosome function and/or spindle organisation
ppears to be an important, indeed fundamental mechanis-
ic cause of severe microcephaly in humans, recent ﬁndings,
sing patient-derived cell lines from Meier–Gorlin syndrome and
olf–Hirschhorn syndrome, suggest that impairments in DNA
eplication efﬁciency also underlie complex human disorders asso-
iated with microcephaly. In the case of Meier–Gorlin syndrome,
utations in various components of the ORC cause this con-
ition. Speciﬁcally in the case of ORC1-mutated patient-derived
CLs, delayed entry into and progression through S phase has
een demonstrated in these cells. Regarding Wolf–Hirschhorn
yndrome, haploinsufﬁciency of SLBP and/or NELF-A/WHSC2 are
ssociated with impaired histone deposition and remodelling dur-
ng S phase, resulting in reduced DNA synthesis and S phase
rogression, likely also impacting upon the preservation of epi-
enetic memory in this context. Both disorders illustrate how
iffering fundamental defects in events at the replication fork can
esult in similar impairments to DNA replication: impairments
trongly associated with abnormal neurogenesis.
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